Chemoinformaics analysis of (-)-epicatechin-3-O--glucopyranoside
| Molecular Weight | 452.412 | nRot | 4 |
| Heavy Atom Molecular Weight | 428.22 | nRig | 23 |
| Exact Molecular Weight | 452.132 | nRing | 4 |
| Solubility: LogS | -3.01 | nHRing | 2 |
| Solubility: LogP | -0.757 | No. of Aliphatic Rings | 2 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 56 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 32 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 21 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 11 | No. of Arom Bond | 12 |
| nHA | 11 | APOL | 59.895 |
| nHD | 8 | BPOL | 29.285 |
| QED | 0.285 |
| Synth | 4.277 |
| Natural Product Likeliness | 2.534 |
| NR-PPAR-gamma | 0.581 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.002 |
| Pgp-sub | 0.497 |
| HIA | 0.846 |
| CACO-2 | -6.543 |
| MDCK | 0.0000181 |
| BBB | 0.464 |
| PPB | 0.815756 |
| VDSS | 0.745 |
| FU | 0.217219 |
| CYP1A2-inh | 0.016 |
| CYP1A2-sub | 0.041 |
| CYP2c19-inh | 0.008 |
| CYP2c19-sub | 0.069 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.594 |
| CYP2d6-inh | 0.018 |
| CYP2d6-sub | 0.227 |
| CYP3a4-inh | 0.019 |
| CYP3a4-sub | 0.045 |
| CL | 6.068 |
| T12 | 0.461 |
| hERG | 0.019 |
| Ames | 0.331 |
| ROA | 0.133 |
| SkinSen | 0.124 |
| Carcinogencity | 0.083 |
| EI | 0.009 |
| Respiratory | 0.025 |
| NR-Aromatase | 0.655 |
| Antiviral | Yes |
| Prediction | 0.736288 |